Cancer care is changing faster than ever before. Around the world, researchers and doctors are developing treatments that are not only more effective, but also more precise and, in many cases, gentler on the body. While every patient’s journey is unique, understanding these advances can help patients and caregivers feel more informed and hopeful.
Precision Medicine: Treating the Cancer, Not Just the Organ
In the past, cancers were mainly treated based on where they started – such as lung cancer or breast cancer. Today, doctors increasingly look at the genetic makeup of the tumour itself.1
Precision medicine uses genetic testing to identify specific changes (mutations) in cancer cells. Treatments can then be chosen to target these changes directly. This means receiving a therapy designed specifically for the biology of their cancer rather than a one-size-fits-all approach. This approach can1
Improve treatment effectiveness
Reduce risk of side effects
Decrease treatment costs
Overall, precision medicine represents a shift toward more individualized cancer care, where treatment decisions are guided by the unique characteristics of each patient’s cancer.1
Immunotherapy: Helping the Immune System Fight Cancer
Immunotherapy is a type of cancer treatment that works by helping your immune system recognize and eliminate cancer cells. Under normal circumstances, the immune system can detect abnormal cells, but cancer cells may develop mechanisms that allow them to evade destruction by the immune system. Immunotherapy is designed to counteract these mechanisms.2
Key types of immunotherapy include2
Immune checkpoint inhibitors: These inhibitors block immune checkpoints that normally regulate immune responses. By blocking these checkpoints, immune cells are able to respond more strongly to cancer.
Monoclonal antibodies: These antibodies are laboratory‑engineered immune proteins designed to bind to specific targets on cancer cells. Some monoclonal antibodies help the immune system better identify and destroy cancer cells.
Cancer treatment vaccines: These vaccines stimulate the immune system’s response against existing cancer cells and are different from vaccines used to prevent infectious diseases.
Tcell transfer therapy (also called adoptive cell therapy): In this, the patient’s own immune cells are used to fight cancer.
Over the past decade, immunotherapy – particularly immune checkpoint inhibitors – has become a major advance in cancer treatment. The first immune checkpoint inhibitor, ipilimumab, was approved by the US Food and Drug Administration (FDA) in 2011 for metastatic melanoma. Since then, the use of these therapies has expanded steadily.3
As of mid-2023, the FDA has approved multiple immune checkpoint inhibitors for the treatment of many cancer types, including cancers that share certain molecular characteristics regardless of where they started in the body. In parallel, other forms of immunotherapy – such as CAR T-cell therapies – have also received FDA approval, particularly for certain blood cancers.3
Although these advances represent major progress, immunotherapy does not work for all patients, and access to these advanced therapies is challenging. Ongoing research continues to focus on improving responses and expanding the range of cancers that can be treated with immunotherapy.3
Targeted Therapies: More Focused, Fewer Side Effects
Targeted therapies are cancer treatments designed to act on specific molecules involved in cancer cell growth and survival. Unlike traditional chemotherapy, they focus on features of cancer cells, which can help limit damage to healthy cells. These treatments are a key part of precision medicine.4
Targeted therapies work in different ways, such as blocking signals that drive cancer growth, preventing tumours from forming new blood vessels, delivering toxic substances directly to cancer cells, or interfering with hormone-driven growth in certain cancers.4
Many targeted therapies are smallmolecule drugs, and they may be used alone or in combination with other treatments, depending on the cancer type and its molecular characteristics.4
Advances in Radiation Therapy: Greater Accuracy, Better Protection
Radiation therapy continues to be a vital part of cancer care, using high-energy rays to damage the DNA of cancer cells so they can no longer grow or spread. It can be used by itself or in combination with surgery, chemotherapy, or other treatments.5
Technological improvements have greatly enhanced how radiation is delivered5:
More precise targeting: Modern techniques like intensity modulated radiation therapy and image-guided radiation therapy shape radiation beams to match the tumour’s contours and use advanced imaging to guide delivery, reducing exposure to healthy tissue.
Higher doses in fewer sessions: Methods such as stereotactic body radiation therapy can deliver powerful doses in a smaller number of treatments, which may improve tumour control and convenience.
Advanced particle therapy: Newer forms such as proton therapy allow radiation to stop at specific depths, potentially limiting damage to surrounding organs – especially useful for tumours near sensitive structures or in children.
Some of these radiation techniques may be expensive and not widely available, which can limit access for patients. Continued research and technological progress are focused on making modern radiation therapy more effective while gradually improving affordability and reach.5
CART Cell Therapy: Advances in Blood Cancer Treatment
Chimeric antigen receptor (CAR)T cell therapy is an advanced form of immunotherapy that uses a patient’s own T cells to fight cancer. In this approach, T cells are collected from the blood, genetically modified in a laboratory to recognize cancer cells, and then infused back into the patient.6
What makes CART therapy different6:
It is a personalized treatment made from the patient’s own immune cells
The modified T cells can multiply in the body and actively seek out cancer cells
It is currently used mainly for certain blood cancers, such as leukaemia, lymphoma and multiple myeloma
Several CART treatments are now approved for patients whose cancer has not responded to other therapies. Although CART therapy is not suitable for everyone and is still being studied for solid tumours, ongoing research aims to make it safer, more effective, and available to more patients.6
Access Remains a Major Challenge
While oncology treatments are advancing rapidly, access to these innovations is not the same for everyone.
Many newer therapies are approved only in certain countries or available at a limited number of specialized centres.7
High costs and complex treatment requirements and training restrict availability, particularly in low- and middle-income regions.7
As cancer science moves forward, improving access to approved therapies across regions remains a critical step in ensuring that breakthroughs translate into real benefits for patients everywhere.
In regions where cutting-edge treatments are not yet locally available, Rx4U can support patients and healthcare providers by assisting with documentation, regulatory coordination, and import logistics. This guidance helps reduce delays and administrative burdens, allowing patients to begin treatment as smoothly and quickly as possible.
Final Takeaway
Cancer care is becoming more personalized and precise.
New treatments can improve outcomes and reduce side effects.
Treatment options vary, so it’s important to talk with your doctor.
Research continues, offering hope for even better treatments in the future.
Medical Disclaimer
This information is provided for educational purposes only and is not a substitute for professional medical advice.
References:
Mishra NP, Nirmal AK, Mishra OA. Precision medicine in cancer biology: using genetic and molecular profiling to personalize treatment. Int J Res Innovation Applied Sci. 2024;9(2):233-238. doi:10.51584/IJRIAS.2024.90219
Immunotherapy to treat cancer. NIH: National Cancer Institute. Updated September 24, 2019. Accessed January 21, 2026. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy
American Association for Cancer Research. AACR Cancer Progress Report 2023. Accessed January 21, 2026. https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2023/09/AACR_CPR_2023.pdf
Targeted therapy to treat cancer. NIH: National Cancer Institute. Updated May 31, 2022. Accessed January 21, 2026. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies
Lee J. The future of cancer treatment: Advances and benefits of radiation therapy. J Cancer Immunol Ther. 2024;7(4):220.
CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers. NIH: National Cancer Institute. Updated February 26, 2025. Accessed January 21, 2026. https://www.cancer.gov/about-cancer/treatment/research/car-t-cells
Anaya JM, Herrán M, Pino LE. Challenges and opportunities for precision medicine in developing nations. Expert Rev Precis Med Drug Dev. 2025;10(1):1-5.
Comments
Post a Comment